LyGenesis Receives Award from Breakthrough T1D® to Fund a Research Project to Induce Immune Tolerance to Pancreatic Islet Transplantation PR Newswire (Press Release) 13:48
Cir-0602K Begins Dosing in Breakthrough T1D-Supported Phase 2 in Type 1 Diabetes PR Newswire (Press Release) 21:20 Wed, 24 Jun
Tzield Approved to Delay Insulin Decline in Pediatric Stage 3 T1D Endocrinology Advisor 15:40 Wed, 17 Jun
No Cnpv needed? Sanofi’s Tzield gains accelerated nod in stage 3 T1D BioWorld 21:43 Mon, 15 Jun Article paywall
Breakthrough T1D Presents New Jersey Resident Gina Gehan with the 2025 Huntsman Family Community Engagement Award PR Newswire (Press Release) 20:53 Mon, 15 Jun
Breakthrough T1D Celebrates Approval of Tzield for use in Stage 3 Type 1 Diabetes in the US PR Newswire (Press Release) 01:57 Sat, 13 Jun
ADA26: Early data for teplizumab demonstrates promise for slowing T1D progression Pharmaceutical Technology 17:06 Tue, 09 Jun
Tandem secures CE mark for AID systems in T2D and T1D with pregnancy Verdict Medical Devices 11:40 Mon, 08 Jun
Breakthrough T1D and Sub-Zero Group Foundation Announce National Partnership to Support Type 1 Diabetes Research PR Newswire (Press Release) 16:42 Tue, 02 Jun
Drug Sheds 28% of Weight; Universal T1D Screening? Lilly Accuses Church of Fraud Medpage Today 19:24 Tue, 26 May
